News August 31, 2021 2021 BPI Readers’ Choice Awards – Downstream Nominees Regardless of molecule, the goal of biopharmaceutical downstream processing is to reduce process- and product-related… Super User Love0
News August 31, 2021 BARDA seeks partners to develop agnostic diagnostic assays On August 23, 2021, BARDA's Division of Research, Innovation, and Ventures (DRIVe) opened a new… Super User Love0
News August 30, 2021 2021 BioHealth Capital Region Mon, Sep 13, 2021 ONLY TWO WEEKS LEFT TO REGISTER Maryland, Virginia, and Washington, DC set the bar high… Super User Love0
News August 30, 2021 NCATS Small Business Funding: Resources and Tips to Commercialize Your Translational Science Innovation Join the National Center for Advancing Translational Sciences (NCATS) in collaboration with the Biotechnology Innovation… Super User Love0
News August 30, 2021 NIA Fellow Daniela Lecca Joins BHI as New Postdoc Fellow Daniela Lecca completed her education in Italy, where she received her Ph.D. in Toxicology from… Super User Love0
BioTalk with Rich Bendis Podcast August 30, 2021 Maryland State Delegate, Lily Qi, Returns to BioTalk with Rich Bendis Lily Qi, Representative for the 15th legislative district in the Maryland House of Delegates. Joins… Super User Love0
News August 30, 2021 Maryland State Delegate, Lily Qi, Returns to BioTalk with Rich Bendis Lily Qi, Representative for the 15th legislative district in the Maryland House of Delegates. Joins… Super User Love0
News August 30, 2021 Maryland-based Emergent BioSolutions begins trials of its plasma-derived therapy for COVID Emergent BioSolutions Inc. is conducting phase clinical 3 trials of its plasma-derived therapy for outpatient… Super User Love0
News August 30, 2021 Machine learning in cardiovascular trials Automating adjudication of events in cardiovascular trials Clinical trials for cardiovascular (CV) disease are time… Super User Love0
News August 30, 2021 A public-private partnership is needed to develop new antivirals – STAT The U.S. government’s announcement that it is investing $3 billion into research on antiviral medicines… Super User Love0